Presenter: Yeh-Han Wang M.D.

Similar documents
How to Recognize Gynecologic Cancer Cells from Pelvic Washing and Ascetic Specimens

A female adnexal tumor of probable Wolffian origin showing positive O-6-methylguanine-DNA methyltransferase methylation

Case Report Wolffian tumor: report of five cases and review of literature

Current Concept in Ovarian Carcinoma: Pathology Perspectives

The role of immunohistochemistry in surgical pathology of the uterine corpus and cervix

A case of female adnexal tumor of probable Wolffian origin: significance of MRI findings

Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

International Society of Gynecological Pathologists Symposium 2007

Case Report Sertoli-Leydig cell tumor with heterologous element: a case report and a review of the literature

Mucinous Tumors of the Ovary Beirut, Lebanon. Anaís Malpica, M.D. Professor Department of Pathology

Article begins on next page

of 20 to 80 and subsequently declines [2].

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Diagnostically Challenging Cases in Gynecologic Pathology

Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

05/07/2018. Types of challenges. Challenging cases in uterine pathology. Case 1 ` 65 year old female Post menopausal bleeding Uterine Polyp

The Diagnostic Challenges of Low Grade and High Grade Tubo-Ovarian Serous Carcinomas. W Glenn McCluggage Belfast, Northern Ireland

Interesting Cases in Gynecologic Pathology. Michael Ward, MD Surgical Pathology Fellow University of Utah Health Sciences Center Salt Lake City, UT

Ovarian Clear Cell Carcinoma

Case Report Poorly Differentiated Thyroid Carcinoma Arising in Struma Ovarii

ENODMETRIAL CARCINOMA: SPECIAL & NOT SO SPECIAL VARIANTS

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Case Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan

Endometrial adenocarcinoma icd 10 code

Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Case 1. Pathology of gynecological cancer. What do we need to know (Case 1) Luca Mazzucchelli Istituto cantonale di patologia Locarno

Low-grade serous neoplasia. Robert A. Soslow, MD

Section 1. Biology of gynaecological cancers: our current understanding

Enterprise Interest Nothing to declare

Molecular Subtyping of Endometrial Cancer: A ProMisE ing Change

Wendy L Frankel. Chair and Distinguished Professor

Staging and Treatment Update for Gynecologic Malignancies

Renal tumours: use of immunohistochemistry & molecular pathology. Dr Lisa Browning John Radcliffe Hospital Oxford

CONTINUING EDUCATION IN TOXICOLOGIC PATHOLOGY REPRODUCTIVE SYSTEM

Case Report Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report

Brief History. Identification : Past History : HTN without regular treatment.

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

MR Findings of Extrauterine Mu llerian Adenosarcoma Associated with Deep Pelvic Endometriosis 1

Case 4 Diagnosis 2/21/2011 TGB

Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

Case E1. Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour

Tinh hoàn

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?

Normal endometrium: A, proliferative. B, secretory.

Case Report Multicentric Infarcted Leiomyoadenomatoid Tumor: A Case Report

A 25 year old female with a palpable mass in the right lower quadrant of her abdomen

Diagnostic IHC in lung and pleura pathology

Disclosure. Case. Mixed Tumors of the Uterine Corpus and Cervix. I have nothing to disclose

A case of extremely rare ovarian tumor: Primary ovarian adenomyoma

What s (new) and Important in Reporting of Uterine Cancers Katherine Vroobel The Royal Marsden

3/27/2017. Disclosure of Relevant Financial Relationships

بسم هللا الرحمن الرحيم. Prof soha Talaat

Case # 4 Low-Grade Serous Carcinoma (Macropapillary) of the Ovary Arising in an Atypical Proliferative Serous Tumor

Case 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:

Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study

Mammary analogue secretory carcinoma of salivary gland A case report of new entity

Pathology of the Thyroid

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016

What really matters When and Why. Pathology of Uterine Mesenchymal Lesions. Nafisa Wilkinson London

A Practical Approach to Adnexal Masses

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

GOBLET CELL CARCINOID

Ovarian carcinoma classification. Robert A. Soslow, MD

Endometrial adenocarcinoma icd 10 code

ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Endometrial Stromal Sarcoma

3 cell types in the normal ovary

Note: The cause of testicular neoplasms remains unknown

Uterine Tumors Resembling Ovarian Sex Cord Tumor in Postmenopausal Woman

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Select problems in cystic pancreatic lesions

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

64 YO lady THBSO for prolapse At gross : A 3 cm endometrial polyp in the fundus

ACCME/Disclosures. M31078/07 Ondřej Hes 4/13/2016

Can diffusion weighted imaging distinguish between benign and malignant solid or predominantly solid gynecological adnexal masses?

Unknown Slides Conference

VULVAR CARCINOMA. Page 1 of 5

Diagnosi, inquadramento clinico e chirurgia

Definition of Synoptic Reporting

ESS: Pathologic Insights

04/09/2018. Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances

Immunohistochemical classification of lung carcinomas and mesotheliomas. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Adenocarcinoma of the Cervix

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

University Journal of Pre and Para Clinical Sciences

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

Histological Typing Of Cancer And Precancer Of The Oral Mucosa

Differential diagnosis of HCC

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Case Report Overlap of microcystic stromal tumor and primary solid pseudopapillary neoplasm of the ovary

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

Transcription:

Korea-Taiwan-Japan Joint Meeting for Gynecological Pathology Mini-lecture Female Adnexal Tumor of Probable Wolffian Origin (FATWO) in Taiwan: A Small Case Series and Literature Review Presenter: Yeh-Han Wang M.D. Department of Anatomic Pathology, Taipei Institute of Pathology, Taiwan

Outlines Introduction & Literature Review Case Series Morphology Immunohistochemical profiles Genetic profiles Take Home Message

Introduction: Female Adnexal Tumor of Probable Wolffian Origin (FATWO) Rare extraovarian, extratubal tumors firstly reported by Kariminejad and Scully in a 9-case series in 1973. Currently an epithelial tumor of Wolffian (mesonephric) origin. Most of the cases are benign or indolent tumors confined within adnexa. Low grade malignant potential or aggressive behaviors in a minor (10%) cases Recurrence / Metastasis

Location & Gross Features Often in broad ligament, mesosalpinx, ovarian hilus and pelvis.

Location & Gross Features Often in broad ligament, mesosalpinx, ovarian hilus and pelvis. Encapsulated, solid ovoid masses with nodular, or lobulated appearance.

Three Pattern in the Original Article Solid or diffuse arrangement Closely packed, winding, branching, and anastomosing tubules A sieve-like pattern with hollow tubules varying in size and shape with occasional cyst formation

Three Pattern in the Original Article

Case Series

Case Series in Taiwan An inter-institutional review Four cases (1 benign, 3 malignant) retrieved All arising from adnexa of middle to old age women (50~63 y/o) Size varies from <1 cm to 16 cm 3 malignant cases Radical surgery and chemotherapy One with local recurrence Follow-up interval: 12~51 months All alive with or without diseases

Case Series in Taiwan Case Age primary site Surgery Chemo Interval of F/U Current status 1 60 right fallopian tube salpingooophorectomy N Loss of F/U 2 50 right adnexa Staging surgery Y 12 months alive 3 61 left ovary Staging surgery Y 42 months alive 4 63 left ovary Staging surgery Y 51 months alive, recur once

Microscopic finding in four cases

Case 1 Sieve-like pattern

Case 2 Solid and sievelike pattern

Case 3 Solid and tubular pattern

Case 4 Spindle cell morphology

Summary in morphology Sieve-like and tubular pattern are most characteristic. Solid or spindle cell morphology would cause difficulty in diagnosis Try to find minor sieve-like or tubular components Malignant cases defined by nuclear atypia, infiltrative growth pattern and frequent mitoses The nuclear grading is not so high grade to fit in typical high grade carcinoma or sarcoma

How to Make Differential Diagnosis? Gross examination Primary site? Ovary? Tube? Others? Microscopic examination Diffuse pattern Tubular pattern Sieve-like pattern Spindle cell morphology

R t tumor

R t OV+tube

How to Making Differential Diagnosis? Diffuse pattern Un-/Poorly-differentiated carcinoma? Neuroendocrine carcinoma? Tubular pattern Endometrioid adenocarcinoma? Granulosa cell tumor? Sertoli (-leydig) cell tumor? Sieve-like pattern Endometrioid adenocarcinoma? Granulosa cell tumor? Adenomatoid tumor/mesothelioma? Spindle cell morphology Adenomatoid tumor/mesothelioma? Fibroma/Thecoma? Sarcoma? (Leiomyosarcoma? Endometrial stromal sarcoma?)

Immunohistochemical profiles

1 2 3 4 CK

EMA 1 2 3 4 Not performed

1 2 3 4 Inhibin

1 2 3 4 Calretinin

CD 10 1 2 3 4 Not available, also positive

Are General Markers Helpful? Case 1 2 3 4 CK + + + + EMA - - Focal + / Inhibin - - Weak + - Calretinin + + - - CD10 Focal + Focal + + +

Int J Gynecol Pathol Vol 35, No. 2 March 2016 1 2 PAX8

Summary in IHC profiles Markers with diffuse expression Pan-CK / Calretinin / Vimentin Markers with variable expression Inhibin / Hormonal marker (ER/PR) / CD10 Marker for differential diagnosis Inhibin / Pax-8 / CD10 A Possible Panel Pan-CK / Calretinin / Inhibin / CD10 / Pax-8

Pathology International 2006; 56:95-100 2 4 CD117

Genetic Profiles CD117 (c-kit) expression: not necessarily relating to genetic mutation on c-kit and PDGFR gene (Harada, et al. Pathology International 2006; 56: 95-100) NGS analysis revealing FATWO a genetically heterogeneous tumor (Cossu, et al. Int J Gynecol Pathol 2017 (Epub ahead)) Three cases, three pathways: CTNNB1 + MET / PIK3CA / BRAF + CDKN2A

Take Home Message FATWOs are rare and possibly misdiagnosed. Identification of characteristic Sieve-like and tubular pattern would be helpful in diagnosis Using an IHC panel would be also helpful Pan-CK / Calretinin / Inhibin / CD10 / Pax-8 Heterogeneity in genetics No histological criterion predicting clinical behavior, and no standard treatment medication

Acknowledgement Dr. Chiung-Ru Lai (Taipei Veterans General Hospital) Dr. Tsui-Lien Mao (National Taiwan University Hospital) Dr. Yee-Jee Jan and Dr. Chih- Ying Wu (Taichung Veteran General Hospital) Dr. Wan-Lin Shen and Dr. Sheng- Tsung Chang (Chi-Mei Hospital).

Thank you for your attention